The American Heart Association has honored University of Louisville professor Roberto Bolli with the 2008 Distinguished Scientist Award. Bolli is professor of medicine, chief of the Division of Cardiovascular Medicine, director of the Institute of Molecular Cardiology and vice chair for research in the Department of Medicine at the University of Louisville. For the past three decades, Bolli’s research has focused on preventing the damage that occurs during heart attacks.
Louisville-based energy consulting and management company Fellon-McCord & Associates has acquired of the assets of DaCott Power & Transmission Solutions LLC (DP&T) from DaCott Energy Services Ltd. of Houston, Texas. The acquisition gives Fellon-McCord a new slate of power supply consulting services, including a 24/7 power dispatch capability benefiting municipalities and energy cooperatives. As part of the purchase agreement, Patrick W. Frazier, former vice president of energy operations for DP&T, will join Fellon-McCord as director of Fellon-McCord’s newly formed Power Supply Group. Fellon-McCord’s new group will operate from its Louisville headquarters as part of the company’s Electric Power Consulting and Management Services division.
ResCare, Inc. has acquired Care Resources, a staffing services company that provides educational, therapeutic, nursing and technical support to students with special needs in schools, hospitals or homes. Care Resources is headquartered in Baltimore, Md., with a hub in Tucson, Ariz., and has annual revenues of approximately $13 million.
CIO magazine has chosen Bruce J. Goodman, senior vice president and chief service and information officer of Louisville-based Humana Inc., as a 2008 inductee into the magazine’s Hall of Fame. Goodman is one of 12 honorees selected this year for profoundly shaping the technology-enabled business landscape and for significant contributions to the technology profession. Goodman’s accomplishments at Humana include leading Humana’s successful joint venture with Blue Cross and Blue Shield of Florida Inc. to form Availity LLC, an Internet-based multi-payor physicians portal; implementing SmartSummary, the nation’s first in-depth, monthly benefits summary tailored specifically to individual health plan members; and innovating with technology and process re-engineering to drive consumer engagement in health decision-making.
Louisville-based River Road Asset Management has exercised its option to purchase the 45 percent minority ownership interest held by Fortis Bank. Financing for the transaction was provided by Asset Management Finance, a New York company that specializes in providing capital to investment firms with successful track records. AMF provided the capital in exchange for a limited-term revenue share interest. During the period of the agreement, AMF will hold a passive, non-voting interest in the firm.
General Electric’s Louisville-based Consumer and Industrial Division has informed employees that it plans to cut business travel and service purchasing by 20 percent, along with a 10 percent reduction of telecommunications costs. A hiring freeze has also been implemented and pay increases for salaried employees are being re-evaluated. In a memo to employees, GE officials said the company is looking at numerous options to reduce complexity and costs, including potential reorganizations and reductions in employment levels.
The James Graham Brown Foundation has committed $20 million over the next five years to the University of Louisville to benefit the cancer center that bears its name. The money will help recruit researchers, especially those who also are experts in clinical care. Research funding at the Brown Cancer Center has increased from less than $1 million in 1999 to more than $51 million in 2007. The cancer center has recruited more than 90 new doctors and researchers to Louisville, with recent research breakthroughs including advances in adult stem-cell biology; anti-cancer vaccines; nontoxic, targeted cancer therapies; and studies of cancer cell metabolism that provide a road map for future drug development.